| 產(chǎn)品編號(hào) | bs-0356R |
| 英文名稱 | Rabbit Anti-Digoxin antibody |
| 中文名稱 | 地高辛抗體 |
| 別 名 | Digoxigenin; Lanoxin. |
 |
Specific References (6) | bs-0356R has been referenced in 6 publications.
[IF=6.304] Hongmei Liu. et al. A novel N6-methyladenosine (m6A)-dependent fate decision for the lncRNA THOR. Cell Death Dis. 2020 Aug;11(8):1-15 IF ; Human.
[IF=5.108] Lu XP et al. Divergent molecular evolution in glutathione S-transferase conferring malathion resistance in the oriental fruit fly, Bactrocera dorsalis (Hendel). Chemosphere. 2019 Oct 25;242:125203. IHF ; Bactrocera dorsalis.
[IF=4.019] Liang Z et al. SERS-based cascade amplification bioassay protocol of miRNA-21 by using sandwich structure with biotin–streptavidin system. Analyst. 2019 Feb 25;144(5):1741-1750. Other ;
[IF=2.87] Gui, S‐H., et al. "Molecular characterizations of natalisin and its roles in modulating mating in the oriental fruit fly, Bactrocera dorsalis (Hendel)." Insect Molecular Biology (2016). IHC-P ; Other Species.
[IF=2.791] Gang Li. et al. Molting process revealed by the detailed expression profiles of RXR1/RXR2 and mining the associated genes in a spider mite, Panonychus citri. 2021 May 20
[IF=2.447] Min Lei. et al. Long non?coding RNA TUG1 sponges microRNA?9 to protect podocytes from high glucose?induced apoptosis and mitochondrial dysfunction via SIRT1 upregulation. Exp Ther Med. 2022 Mar;23(3):1-9 ISH ; Mouse.
|
| 產(chǎn)品類型 | 小分子抗體 |
| 研究領(lǐng)域 | 細(xì)胞生物 免疫學(xué) 藥物及化合物 |
| 抗體來源 | Rabbit |
| 克隆類型 | Polyclonal |
| 交叉反應(yīng) | (predicted: Digoxin) |
| 產(chǎn)品應(yīng)用 | ELISA=1:5000-10000
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 理論分子量 | 0.78 kDa |
| 檢測分子量 | |
| 性 狀 | Liquid |
| 濃 度 | 1mg/ml |
| 免 疫 原 | BSA conjugated Digoxin |
| 亞 型 | |
| 純化方法 | affinity purified by Protein A |
| 緩 沖 液 | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| 保存條件 | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| PubMed | PubMed |
| 產(chǎn)品介紹 |
Digoxin is a beta blocker drug originally derived from the foxglove plant, Digitalis lanata. Digoxin is used primarily to improve the pumping ability of the heart in congestive heart failure (CHF), and treat problems such as high blood pressure. It is also used to help normalize some dysrhythmias (abnormal types of heartbeat). 1.用于治療充血性心力衰竭，對(duì)于高血壓、瓣膜病、先天性心臟病所引起的充血性心力衰竭療效良好。對(duì)繼發(fā)于嚴(yán)重貧血、甲狀腺功能低下及維生素Bl缺乏癥的充血性心力衰竭則治療效果差；對(duì)于肺源性心臟病、心肌嚴(yán)重缺血或活動(dòng)性心肌炎及心肌外機(jī)械因素所致心力衰竭療效也差。 2.用于控制快速性心房顫動(dòng)、心房撲動(dòng)的心室率。 |
